Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw as Exclusive Placement Agent for a $5 Million Registered Direct Offering
Press Release – New York, NY – August 26, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright& Co., LLC, as the exclusive placement agent for a registered direct offering of CEL-SCI Corporation (NYSE MKT: CVM), a pharmaceutical company that is focused on finding the best way to activate a patient’s immune response to fight cancer and infectious diseases (“CEL-SCI”).
CEL-SCI sold an aggregate of 10 million shares of common stock at a price of $0.50 per share and warrants to purchase 5 million shares of common stock at an exercise price of $0.55 per share.
The securities described above were offered and sold by CEL-SCI pursuant to an effective shelf registration statement on Form S-3.
The Sichenzia Ross Friedman Ference LLP team was led by Gregory Sichenzia, Stephen Cohen and Jay Yamamoto.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement - April 10, 2019
- Sichenzia Ross Ference LLP Congratulates INmune Bio Inc., on Initial Public Offering - April 10, 2019
- FDA sets first hearing on CBD in May as the agency looks at legalizing the cannabis compound in food and drinks - April 4, 2019